Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

NASDAQ:CETX - Nasdaq - US15130G8814 - Common Stock - Currency: USD

1.07  +0.02 (+1.9%)

After market: 1.04 -0.03 (-2.8%)

Fundamental Rating

3

Overall CETX gets a fundamental rating of 3 out of 10. We evaluated CETX against 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of CETX have multiple concerns. CETX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CETX had negative earnings in the past year.
In the past year CETX had a positive cash flow from operations.
In the past 5 years CETX always reported negative net income.
In the past 5 years CETX always reported negative operating cash flow.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

CETX has a Return On Assets of -53.90%. This is amonst the worse of the industry: CETX underperforms 87.20% of its industry peers.
CETX has a Return On Equity of -389.20%. This is amonst the worse of the industry: CETX underperforms 97.60% of its industry peers.
Industry RankSector Rank
ROA -53.9%
ROE -389.2%
ROIC N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

CETX has a better Gross Margin (42.43%) than 73.60% of its industry peers.
In the last couple of years the Gross Margin of CETX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CETX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CETX has less shares outstanding
Compared to 5 years ago, CETX has less shares outstanding
CETX has a better debt/assets ratio than last year.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -1.07, we must say that CETX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.07, CETX is doing worse than 85.60% of the companies in the same industry.
A Debt/Equity ratio of 1.48 is on the high side and indicates that CETX has dependencies on debt financing.
With a Debt to Equity ratio value of 1.48, CETX is not doing good in the industry: 94.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Altman-Z -1.07
ROIC/WACCN/A
WACC4.13%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

CETX has a Current Ratio of 1.21. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
CETX's Current ratio of 1.21 is on the low side compared to the rest of the industry. CETX is outperformed by 88.00% of its industry peers.
A Quick Ratio of 0.95 indicates that CETX may have some problems paying its short term obligations.
CETX has a worse Quick ratio (0.95) than 82.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.95
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

CETX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -564.41%.
The Revenue has grown by 12.93% in the past year. This is quite good.
The Revenue has been growing by 11.21% on average over the past years. This is quite good.
EPS 1Y (TTM)-564.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.42%
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%58.8%

3.2 Future

The Earnings Per Share is expected to grow by 89.28% on average over the next years. This is a very strong growth
Based on estimates for the next years, CETX will show a quite strong growth in Revenue. The Revenue will grow by 15.00% on average per year.
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 100K -100K 200K -200K 300K

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
CETX is valuated cheaply with a Price/Forward Earnings ratio of 0.52.
Based on the Price/Forward Earnings ratio, CETX is valued cheaper than 100.00% of the companies in the same industry.
CETX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE N/A
Fwd PE 0.52
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CETX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.34
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CETX's earnings are expected to grow with 89.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEMTREX INC

NASDAQ:CETX (6/27/2025, 8:00:00 PM)

After market: 1.04 -0.03 (-2.8%)

1.07

+0.02 (+1.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-12 2025-08-12
Inst Owners9.77%
Inst Owner Change-58.63%
Ins Owners0%
Ins Owner Change0%
Market Cap1.90M
Analysts82.86
Price TargetN/A
Short Float %21.7%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.52
P/S 0.03
P/FCF N/A
P/OCF 4.72
P/B 0.3
P/tB 0.71
EV/EBITDA 28.34
EPS(TTM)-610.99
EYN/A
EPS(NY)2.05
Fwd EY191.61%
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)0.23
OCFY21.18%
SpS41.47
BVpS3.6
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.9%
ROE -389.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.43%
FCFM N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Debt/EBITDA 14.16
Cap/Depr 176.61%
Cap/Sales 3.12%
Interest Coverage N/A
Cash Conversion 60.18%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.95
Altman-Z -1.07
F-Score5
WACC4.13%
ROIC/WACCN/A
Cap/Depr(3y)155.23%
Cap/Depr(5y)125.9%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-564.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.42%
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%58.8%
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.5%
OCF growth 3YN/A
OCF growth 5YN/A